A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 286,602 shares of IONS stock, worth $13.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
286,602
Previous 968,800 70.42%
Holding current value
$13.7 Million
Previous $49 Million 74.65%
% of portfolio
0.03%
Previous 0.12%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$42.03 - $53.55 $28.7 Million - $36.5 Million
-682,198 Reduced 70.42%
286,602 $12.4 Million
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $35.9 Million - $42.7 Million
827,300 Added 584.66%
968,800 $49 Million
Q3 2023

Nov 14, 2023

SELL
$38.5 - $47.13 $2.42 Million - $2.96 Million
-62,900 Reduced 30.77%
141,500 $6.42 Million
Q2 2023

Aug 14, 2023

BUY
$34.73 - $43.33 $3.77 Million - $4.7 Million
108,515 Added 113.17%
204,400 $8.39 Million
Q1 2023

May 15, 2023

BUY
$33.58 - $41.2 $3.22 Million - $3.95 Million
95,885 New
95,885 $3.43 Million
Q2 2022

Aug 15, 2022

BUY
$31.71 - $43.0 $418,096 - $566,955
13,185 New
13,185 $488,000
Q1 2022

May 16, 2022

SELL
$29.88 - $37.04 $1.61 Million - $2 Million
-53,981 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$25.61 - $35.1 $4.23 Million - $5.8 Million
-165,319 Reduced 75.38%
53,981 $1.64 Million
Q3 2021

Nov 15, 2021

SELL
$33.54 - $40.55 $25.4 Million - $30.7 Million
-757,600 Reduced 77.55%
219,300 $7.36 Million
Q2 2021

Aug 16, 2021

BUY
$34.54 - $47.25 $33.7 Million - $46.2 Million
976,900 New
976,900 $39 Million
Q1 2021

May 17, 2021

SELL
$42.51 - $63.78 $17.1 Million - $25.7 Million
-402,400 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$45.3 - $60.27 $5.16 Million - $6.87 Million
113,908 Added 39.48%
402,400 $22.8 Million
Q3 2020

Nov 16, 2020

BUY
$47.45 - $62.95 $5.4 Million - $7.17 Million
113,867 Added 65.21%
288,492 $13.7 Million
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $7.92 Million - $10.3 Million
169,052 Added 3033.41%
174,625 $10.3 Million
Q1 2020

May 15, 2020

BUY
$41.6 - $63.4 $231,836 - $353,328
5,573 New
5,573 $263,000
Q4 2018

Feb 14, 2019

SELL
$43.37 - $59.54 $3.73 Million - $5.12 Million
-86,031 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$42.88 - $53.7 $3.69 Million - $4.62 Million
86,031 New
86,031 $4.44 Million
Q4 2017

Feb 14, 2018

SELL
$50.3 - $64.39 $1.26 Million - $1.61 Million
-25,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$45.56 - $59.57 $1.14 Million - $1.49 Million
25,000
25,000 $1.27 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.76B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.